Carrie Krehlik - 01 Sep 2022 Form 4 Insider Report for Global Blood Therapeutics, Inc.

Role
Chief Human Resources Officer
Signature
/s/ Miguel Carrillo, Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
01 Sep 2022
Net transactions value
-$242,069
Form type
4
Filing time
06 Sep 2022, 19:00:31 UTC
Previous filing
03 Mar 2022
Next filing
06 Oct 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GBT Common Stock Options Exercise +8,060 8,060 01 Sep 2022 Direct F1
transaction GBT Common Stock Options Exercise +2,208 +27% 10,268 01 Sep 2022 Direct F1
transaction GBT Common Stock Tax liability $242,069 -3,552 -35% $68.15 6,716 01 Sep 2022 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GBT Restricted Stock Units Options Exercise $0 -8,060 -25% $0.000000 24,180 01 Sep 2022 Common Stock 8,060 Direct F1, F3
transaction GBT Restricted Stock Units Options Exercise $0 -2,208 -12% $0.000000 15,460 01 Sep 2022 Common Stock 2,208 Direct F1, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's Common Stock.
F2 Represents the number of shares of the Issuer's Common Stock withheld to satisfy the Reporting Person's tax obligations in connection with the vesting of 10,268 shares of Common Stock underlying the Reporting Person's RSUs.
F3 The RSUs vest with respect to 25% of the underlying shares on September 1, 2022 and in 6 semi-annual installments thereafter, so long as the Reporting Person continues as an employee or other service provider of the Issuer through each vesting date. The RSUs are subject to accelerated vesting upon termination without cause or resignation for good reason after a change of control of the Issuer.
F4 The shares of Common Stock underlying the RSUs vest in 8 equal semi-annual installments over 4 years from March 1, 2022, so long as the Reporting Person continues as an employee or other service provider of the Issuer through each vesting date. The RSUs are subject to accelerated vesting upon termination without cause or resignation for good reason after a change of control of the Issuer.